Altered hydroxydesipramine concentrations in elderly depressed patients
- 1 January 1982
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 31 (1) , 51-55
- https://doi.org/10.1038/clpt.1982.8
Abstract
Recent reports demonstrate that hydroxy metabolites of desipramine (DMI) have pharmacologic activity and do not just produce side effects. In patients treated with DMI, we determined the ratio of 2‐hydroxydesipramine (2‐OH‐DMI) to drug at steady state. The ratios in the elderly patients were higher than in younger patients, and whereas plasma levels of 2‐OH‐DMI increased with age, urinary clearances decreased. The known decrease in glomerular filtration with age may explain the selective increase of 2‐OH‐DMI concentration in the elderly. Clinical Pharmacology and Therapeutics (1982) 31, 51–55; doi:10.1038/clpt.1982.8This publication has 7 references indexed in Scilit:
- Concentrations of desipramine in elderly womenAmerican Journal of Psychiatry, 1981
- Single-Dose Kinetics Predict Steady-State Concentrations of Imipramine and DesipramineArchives of General Psychiatry, 1980
- High‐Performance Liquid Chromatographic Assay for Imipramine, Desipramine, and Their 2‐Hydroxylated MetabolitesJournal of Pharmaceutical Sciences, 1979
- HYDROXYLATED METABOLITES OF TRICYCLIC ANTI-DEPRESSANTS - PRE-CLINICAL ASSESSMENT OF ACTIVITY1979
- AMITRIPTYLINE PLASMA-CONCENTRATION AND CLINICAL EFFECTThe Lancet, 1978
- Effects of several tricyclic antidepressants on the hemodynamics and myocardial contractility of the anesthetized dogsEuropean Journal of Pharmacology, 1977
- Effect of simultaneous treatment with low doses of perphenazine on plasma and urine concentrations of nortriptyline and 10-hydroxynortriptylineEuropean Journal of Clinical Pharmacology, 1977